Patents by Inventor Veronica Profir

Veronica Profir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM OF 4-(5--4-METHYL-4H-1,2,4-TRIAZOL-3-YL)PYRIDINE
    Publication number: 20110224261
    Abstract: The present invention relates to a novel crystalline form of 4-(5-{(IR)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it.
    Type: Application
    Filed: August 11, 2009
    Publication date: September 15, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Hans Åström, Alexander Minidis, Veronica Profir
  • Crystalline Forms of 2-Hydroxy-3- [5- (Morpholin- 4- Ylmethyl) Pyridin-2-YL] IH- Indole- 5 -Carbonitrile Citrate
    Publication number: 20100267720
    Abstract: The present invention relates to new crystalline forms of 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, a Form D and a Form E, respectively, a process for their preparations, pharmaceutical formulations containing said compounds and to the use of said active compounds in therapy, and particularly to GSK3 related conditions and disorders.
    Type: Application
    Filed: July 29, 2008
    Publication date: October 21, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Anders Erikson, Veronica Profir, Tesfai Sebhatu, Erica Tjerneld
  • Compounds 501
    Publication number: 20100041706
    Abstract: The present invention relates to a novel crystalline form of 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form.
    Type: Application
    Filed: August 11, 2009
    Publication date: February 18, 2010
    Applicant: AstraZeneca AB
    Inventors: Hans Âström, Veronica Profir
  • Compounds for the treatment of neurological, psychiatric or pain disorders
    Patent number: 7476684
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: January 13, 2009
    Assignee: AstraZeneca AB
    Inventors: Alexander Minidis, David Wensbo, Methvin Isaac, Abdelmalik Slassi, Jalaj Arora, Tao Xin, Louise Edwards, Caroline Eriksson, Veronica Profir, Per-Olov Bergstrom
  • 5-(Phenylisoxazolylethoxy) - Triazol- 3 -Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders
    Publication number: 20080227824
    Abstract: The present invention is directed to novel compounds of formula (I)/(II)/(III), their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Application
    Filed: September 20, 2006
    Publication date: September 18, 2008
    Applicant: Astrazeneca AB
    Inventors: Alexander Minidis, David Wensbo, Abdelmalik Slassi, Methvin Isaac, Caroline Ericsson, Veronica Profir, Per-Olov Bergstrom, Louise Edwards, Jalaj Arora, Tao Xin
  • NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
    Publication number: 20070270468
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Application
    Filed: July 27, 2007
    Publication date: November 22, 2007
    Inventors: Alexander MINIDIS, David WENSBO, Methvin ISAAC, Abdelmalik SLASSI, Jalaj ARORA, Tao XIN, Louise EDWARDS, Caroline ERIKSSON, Veronica PROFIR, Per-Olov BERGSTROM
  • NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
    Publication number: 20070270469
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Application
    Filed: July 27, 2007
    Publication date: November 22, 2007
    Inventors: Alexander MINIDIS, David WENSBO, Methvin ISAAC, Abdelmalik SLASSI, Jalaj ARORA, Tao XIN, Louise Edwards, Caroline ERIKSSON, Veronica PROFIR, Per-Olov BERGSTROM
  • New compounds for the treatment of neurological, psychiatric or pain disorders
    Publication number: 20070129408
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Application
    Filed: September 20, 2006
    Publication date: June 7, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS, INC.
    Inventors: Alexander Minidis, David Wensbo, Methvin Isaac, Abdelmalik Slassi, Jalaj Arora, Tao Xin, Louise Edwards, Caroline Eriksson, Veronica Profir, Per-Olov Bergstrom